Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Alcohol dehydrogenase class-3 (ADH5) is a human enzyme encoded by the ADH5 gene, and is a member of the alcohol dehydrogenase family. It operates as a homodimer and is best known for its role as a glutathione-dependent formaldehyde dehydrogenase, catalyzing the oxidation of S-hydroxymethyl-glutathione adducts, thus protecting against formaldehyde toxicity—a carcinogenic and cytotoxic metabolite. ADH5 further acts as S-nitrosoglutathione reductase (GSNOR), regulating nitric oxide signaling and protein S-nitrosylation. These functions are integral to cellular homeostasis, impacting detoxification, DNA repair, airway reactivity, and cardiovascular and immune responses. Deficiency or altered activity of ADH5 is linked to increased risk for cancer, inflammatory conditions (including asthma), Fanconi anemia, and disorders involving redox imbalance. While not directly a drug target in mainstream clinical therapy, ADH5 is actively researched for its biomarker and therapeutic potential, and the instability of its recombinant protein has posed technical challenges.
GSNOR antagonists/inhibitors (increase S-nitrosylation by inhibiting nitrosoglutathione reduction, modulating redox and NO signaling) Formaldehyde scavengers (reduce substrate load, modulating ADH5 activity indirectly)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alcohol dehydrogenase class-3 (glutathione-dependent formaldehyde dehydrogenase) (ADH5).